Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Merck & Company Inc

MRK

Merck & Company Inc

Merck & Company Inc historical holders

total: 18

Gardner Russo & Quinn Merck & Company Inc transactions over time

Total transactions:
35
New positions:
5
Sold out:
4
Added:
10
Reduced:
16
Held since:
2026 Q1
Held for:
1 quarter
Latest activity:
2026 Q1
Thomas Russo has been an institutional investor in Merck & Company Inc (MRK) since at least 2013 Q2. According to 2026 Q1 report, Thomas Russo holds 2,141 shares with a market value of roughly $257.54K representing 0.00% of their equity portfolio. In our earliest available record from 2013 Q2, Gardner Russo & Quinn held 5,736 shares of MRK. Thomas Russo later completely sold out the position and reinvested in MRK again in 2026 Q1. Since at least 2013 Q2, Gardner Russo & Quinn has made 34 more transactions in this position.

Does Thomas Russo still hold MRK?

Yes, Thomas Russo continues to hold Merck & Company Inc (MRK). According to their 2026 Q1 report, they maintain a position of 2,141 shares valued at approximately $257.54K, representing 0.00% of their equity portfolio.

Has Thomas Russo reinvested in MRK after selling?

Yes, Thomas Russo has shown renewed interest in Merck & Company Inc (MRK). After completely selling their position, they reinitiated an investment in 2026 Q1, demonstrating continued conviction in this ticker.

Estimated cost basis*

Weighted AVG buy price:
$120.29

MRK transactions history by Gardner Russo & Quinn

35 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q1
0.00%
2,141
$120.29
$257,536
new
+0%
2025 Q2
0.00%
0
$89.76
-100% (-2,763)
-0%
2025 Q1
0.00%
2,763
$89.76
$248,013
-5.57% (-163)
-0%
2024 Q4
0.00%
2,926
$99.49
$291,104
-5.22% (-161)
-0%
2024 Q3
0.00%
3,087
$113.56
$350,548
-10.42% (-359)
-0%
2024 Q2
0.00%
3,446
$123.79
$426,592
-1.91% (-67)
-0%
2024 Q1
0.00%
3,513
$131.95
$463,550
-7.70% (-293)
-0%
2023 Q4
0.00%
3,806
$109.03
$414,974
-0.94% (-36)
-0%
2023 Q3
0.00%
3,842
$102.95
$395,547
-2.98% (-118)
-0%
2023 Q2
0.00%
3,960
$115.38
$456,921
+3.37% (+129)
+0%
2023 Q1
0.00%
$106.40
+4.30% (+158)
2022 Q4
0.00%
$110.95
-4.80% (-185)
2022 Q3
0.00%
$86.05
-1.30% (-51)
2022 Q2
0.00%
$91.07
+0.26% (+10)
2022 Q1
0.00%
$82.07
+0.28% (+11)
2021 Q4
0.00%
$76.65
+0.26% (+10)
2021 Q3
0.00%
$75.04
+0.26% (+10)
2021 Q2
0.00%
$77.82
+0.26% (+10)
2021 Q1
0.00%
$76.98
-2.18% (-86)
2020 Q4
0.00%
$81.90
+0.23% (+9)
2020 Q3
0.00%
$82.85
+0.23% (+9)
2020 Q2
0.00%
$77.43
+42.71% (+1,175)
2019 Q4
0.00%
$90.88
-1.08% (-30)
2019 Q2
0.00%
$83.78
-0.18% (-5)
2018 Q4
0.00%
$76.45
new
2018 Q1
0.00%
$56.13
-100% (-2,886)
2017 Q4
0.00%
$56.13
new
2016 Q2
0.00%
$52.92
-100% (-3,836)
2015 Q4
0.00%
$52.92
new
2015 Q3
0.00%
$56.83
-100% (-3,836)
2015 Q1
0.00%
$57.35
-11.53% (-500)
2014 Q3
0.00%
$59.27
-1.14% (-50)
2014 Q2
0.00%
$57.91
-3.31% (-150)
2013 Q4
0.00%
$50.04
-20.92% (-1,200)
2013 Q2
0.00%
$46.37
new or own*
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.